Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Belt

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Cancer & Clinical Oncology|April 1, 1983
Effect of mannitol and plasma on the cytotoxicity of cisplatinE E Holdener, C H Park, R J Belt, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of chlorozotocin (NSC-178248): weekly scheduleW J Moriconi, S Taylor, M Slavik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trialH L West, H A Wakelee, M C Perry, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Clinical kinetics on intact cisplatin and some related speciesK J Himmelstein, T F Patton, R J Belt, et al.
Cancer Treatment Reports|September 1, 1979
Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)R J Belt, K J Himmelstein, T F Patton, et al.
Cancer|February 15, 1992
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinomaR Pazdur, J A Ajani, R Winn, et al.
Investigational New Drugs|November 1, 1993
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group studyM M Zalupski, J Benedetti, S P Balcerzak, et al.
Cancer Research|September 1, 1985
Pharmacokinetic and biochemical studies on acivicin in phase I clinical trialsJ P McGovren, E A Pratt, R J Belt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group studyT P Miller, S Dahlberg, S E Salmon, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II trial of vinblastine in patients with advanced or recurrent endometrial carcinoma. A Southwest Oncology Group StudyJ T Thigpen, R Kronmal, S Vogel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|April 1, 1983
Effect of mannitol and plasma on the cytotoxicity of cisplatinE E Holdener, C H Park, R J Belt, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of chlorozotocin (NSC-178248): weekly scheduleW J Moriconi, S Taylor, M Slavik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trialH L West, H A Wakelee, M C Perry, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Clinical kinetics on intact cisplatin and some related speciesK J Himmelstein, T F Patton, R J Belt, et al.
Cancer Treatment Reports|September 1, 1979
Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)R J Belt, K J Himmelstein, T F Patton, et al.
Cancer|February 15, 1992
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinomaR Pazdur, J A Ajani, R Winn, et al.
Investigational New Drugs|November 1, 1993
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group studyM M Zalupski, J Benedetti, S P Balcerzak, et al.
Cancer Research|September 1, 1985
Pharmacokinetic and biochemical studies on acivicin in phase I clinical trialsJ P McGovren, E A Pratt, R J Belt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group studyT P Miller, S Dahlberg, S E Salmon, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II trial of vinblastine in patients with advanced or recurrent endometrial carcinoma. A Southwest Oncology Group StudyJ T Thigpen, R Kronmal, S Vogel, et al.
Pageof 3